The emerging concept of vascular remodeling

New England Journal of Medicine

Volumn 330, Issue 20, 1994, Pages 1431-1438

  Epstein, Franklin H ^a   Gibbons, Gary H ^a   Dzau, Victor J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; ELASTIN; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; FIBRILLIN; INTERLEUKIN 1; INTERLEUKIN 6; LAMININ; NEUROKININ A; NORADRENALIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; SEROTONIN; SOMATOMEDIN; SUBSTANCE P; TENASCIN; THROMBIN; THROMBOXANE; TRANSFORMING GROWTH FACTOR; VASOPRESSIN;

ANGIOPLASTY; ATHEROSCLEROSIS; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; CARDIOVASCULAR AUTOREGULATION; CELL STRUCTURE; DUCTUS ARTERIOSUS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR BINDING; REVIEW; VASCULAR SURGERY; VEIN BYPASS;

ADAPTATION, PHYSIOLOGICAL; ANIMAL; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HEMOSTASIS; HUMAN; REGENERATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VASCULAR DISEASES;

EID: 0028300301     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199405193302008     Document Type: Review

References (90)

1. Mulvany MJ The structure of the resistance vasculature in essential hypertension. J Hypertens 1987; 5: 129-136
2. Owens GK Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol 1989; 257: H1755-H1765
3. Baumbach GL, Heistad DD Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13: 968-972
4. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW Jr Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256: H126-H131
5. Langille BL, O'Donnell F Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986; 231: 405-407
6. Kamiya A, Togawa T Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 1980; 239: H14-H21
7. Davies PF, Tripathi SC Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ Res 1993; 72: 239-245
8. Olesen SP, Clapham DE, Davies PF Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 1988; 331: 168-170
9. Nakache M, Gaub HE Hydrodynamic hyperpolarization of endothelial cells. Proc Natl Acad Sci U S A 1988; 85: 1841-1843
10. Shen J, Luscinskas FW, Connolly A, Dewey CF Jr, Gimbrone MA Jr Fluid shear stress modulates cytosolic free calcium in vascular endothelial cells. Am J Physiol 1992; 262: C384-C390
11. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991; 88: 1663-1671
12. Frangos JA, Eskin SG, McIntire LV, Ives CL Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227: 1477-1479
13. Kuchan MJ, Frangos JA Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264: H150-H156
14. Nishida K, Harrison DG, Navas JP, Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092-2096
15. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A 1993; 90: 4591-4595 [Erratum, Proc Natl Acad Sci U S A 1993;90:7908.]
16. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial TGFb1 transcription and production: modulation by potassium channel blockade. J Clin Invest (in press).
17. Harder DR Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 1987; 60: 102-107
18. Tozzi CA, Poiani GJ, Harangozo AM, Boyd CD, Riley DJ Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest 1989; 84: 1005-1012
19. Iba T, Shin T, Sonoda T, Rosales O, Sumpio BE Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretch. J Surg Res 1991; 50: 457-460
20. Naruse K, Sokabe M Involvement of stretch-activated ion channels in Ca2+ mobilization to mechanical stretch in endothelial cells. Am J Physiol 1993; 264: C1037-C1044
21. Ryan US Endothelium as a transducing surface. J Mol Cell Cardiol 1989; 21: Suppl 1: 85-90
22. Butcher EC Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1036
23. Wang N, Butler JP, Ingber DE Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993; 260: 1124-1127
24. Schwartz SM, Heimark RL, Majesky MW Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990; 70: 1177-1209
25. Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
26. Cunningham LD, Brecher P, Cohen RA Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. J Clin Invest 1992; 89: 878-882
27. Gibbons GH, Pratt RE, Dzau VJ Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461
28. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515-524
29. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268-2274
30. Jackson CI, Schwartz SM Pharmacology of smooth muscle cell replication. Hypertension 1992; 20: 713-736
31. Itoh H, Pratt RE, Dzau VJ Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990; 86: 1690-1697
32. Garg UC, Hassid A Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777
33. Vaux DL Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A 1993; 90: 786-789
34. Bennett MR, Evan GI, Newby AC Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res 1994; 74: 525-536
35. Araki S, Simada Y, Kaji K, Hayashi H Role of protein kinase C in the inhibition of fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 1990; 172: 1081-1085
36. Mayne R Collagenous proteins of blood vessels. Arteriosclerosis 1986; 6: 585-593
37. Majack RA, Goodman LV, Dixit VM Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 1988; 106: 415-422
38. Saksela O, Rifkin DB Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93-126
39. Unemori EN, Bouhana KS, Werb Z Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem 1990; 265: 445-451
40. Sawdey M, Podor TJ, Loskutoff DJ Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 1989; 264: 10396-10401
41. De Clerck YA, Yean T-D, Ratzkin BJ, Lu HS, Langley KE Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 1989; 264: 17445-17453
42. Yamada E, Hazama F, Amano S, Sasahara M, Kataoka H Elastase, collagenase, and cathepsin D activities in the aortas of spontaneously hypertensive and renal hypertensive rats. Exp Mol Pathol 1986; 44: 147-156
43. LoGerfo FW, Quist WC, Cantelmo NL, Haudenschild CC Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation 1983; 68: Suppl II: II-117
44. Lehmann KH, von Segesser L, Muller-Glauser W, Internal-mammary coronary artery grafts: is their superiority also due to a basically intact endothelium? Thorac Cardiovasc Surg 1989; 37: 187-189
45. Kockx MM, Cambier BA, Bortier HE, De Meyer GR, Van Cauwelaert PA The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts. Virchows Arch A Pathol Anat Histopathol 1992; 420: 155-162
46. Golden MA, Au YPT, Kenagy RD, Clowes AW Growth factor gene expression by intimal cells in healing polytetrafluoroethylene grafts. J Vasc Surg 1990; 11: 580-585
47. Rakugi H, Gibbons G, Wang D, Expression of transforming growth factor β 1 in human atherectomy specimens from primary- and restenotic coronary artery lesions. J Am Coll Cardiol 1992; 19: Suppl A: 329A-329A abstract.
48. Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991; 11: 1844-1852
49. Faulkner SL, Fisher RD, Conkle DM, Page DL, Bender HW Jr Effect of blood flow rate on subendothelial proliferation in venous autografts used as arterial substitutes. Circulation 1975; 52: Suppl I: I-163
50. Paty PS, Shah DM, Saifi J, Remote distal arteriovenous fistula to improve infrapopliteal bypass patency. J Vasc Surg 1990; 11: 171-177
51. Luscher TF, Diederich D, Siebenmann R, Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988; 319: 462-467
52. O'Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen PO Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg 1991; 214: 727-732
53. Gittenberger-de Groot AC, van Ertbruggen I, Moulaert AJMG, Harinck E The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 1980; 96: 88-93
54. Zhu L, Dagher E, Johnson DJ, A developmentally regulated program restricting insolubilization of elastin and formation of laminae in the fetal lamb ductus arteriosus. Lab Invest 1993; 68: 321-331
55. Hinek A, Mecham RP, Keeley F, Rabinovitch M Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest 1991; 88: 2083-2094
56. Coceani F, Kelsey L Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol 1991; 69: 218-221
57. Reid LM The control of cellular proliferation in the pulmonary circulation. Am Rev Respir Dis 1989; 140: 1490-1493
58. Mecham RP, Whitehouse LA, Wrenn DS, Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 1987; 237: 423-426
59. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324: 1539-1547
60. Botney MD, Parks WC, Crouch EC, Stenmark K, Mecham RP Transforming growth factor-β1 is decreased in remodeling hypertensive bovine pulmonary arteries. J Clin Invest 1992; 89: 1629-1635
61. Giaid A, Yanagisawa M, Langleben D, Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328: 1732-1739
62. Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res 1989; 64: 814-825
63. Clozel M, Breu V, Burri K, Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993; 365: 759-761
64. Luscher TF, Vanhoutte PM, Raij L Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 1987; 9: Suppl III: III-193
65. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27
66. Sarzani R, Brecher P, Chobanian AV Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 1989; 83: 1404-1408
67. Morishita R, Higaki J, Miyazaki M, Ogihara T Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992; 19: Suppl II: II-62
68. Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S Hypertension: increase of collagen biosynthesis in arteries but not in veins. Science 1977; 198: 403-405
69. Glagov S, Zarins C, Giddens DP, Ku DN Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988; 112: 1018-1031
70. Henney AM, Wakely PR, Davies MJ, Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 1991; 88: 8154-8158
71. Falk E Why do plaques rupture? Circulation 1992; 86: Suppl III: III-30
72. Fuster V, Badimon L, Badimon JJ, Chesebro JH The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250
73. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375
74. Lindner V, Reidy MA Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A 1991; 88: 3739-3743
75. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132
76. Dzau VJ, Gibbons GH, Pratt RE Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 1991; 18: Suppl II: II-100
77. Bjornsson TD, Dryjski M, Tluczek J, Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A 1991; 88: 8651-8655
78. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest 1992; 90: 1582-1592
79. Glukhova MA, Frid MG, Shekhonin BV, Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol 1989; 109: 357-366
80. Raugi GJ, Mullen JS, Bark DH, Okada T, Mayberg MR Thrombospondin deposition in rat carotid artery injury. Am J Pathol 1990; 137: 179-185
81. James TW, Wagner R, White LA, Zwolak RM, Brinckerhoff CE Introduction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J Cell Physiol 1993; 157: 426-437
82. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990; 67: 61-67
83. Kovach JA, Mintz GS, Kent KM, Serial intravascular ultrasound studies indicate that chronic recoil is an important mechanism of restenosis following transcatheter therapy. J Am Coll Cardiol 1993; 21: Suppl A: 484A-484A abstract.
84. Ando J, Nomura H, Kamiya A The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc Res 1987; 33: 62-70
85. Califf RM, Fortin DF, Frid DJ, Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991; 17: Suppl B: 2B-13B
86. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172
87. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
88. Gibbons GH Preventive treatment of graft coronary vascular disease: the potential role of vasodilator therapy. J Heart Lung Transplant 1992; 11: Suppl: S22-S27
89. Schroeder JS, Gao SZ, Alderman EL, A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993; 328: 164-170
90. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW Retardation of angiographic progression of coronary artery disease by nifedipine: results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990; 335: 1109-1113